These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3447427)

  • 1. Encephalopathic toxicity: an experimental model of uremia and solute-specific dialysis.
    Teschan PE; Lipman JJ; Lawrence P; BeBoer D
    Adv Exp Med Biol; 1987; 223():125-9. PubMed ID: 3447427
    [No Abstract]   [Full Text] [Related]  

  • 2. Solutes vs. symptoms in uremia.
    Teschan PE; Lipman JJ; Lawrence P; DeBoer D
    Int J Artif Organs; 1988 Jul; 11(4):232-4. PubMed ID: 3410563
    [No Abstract]   [Full Text] [Related]  

  • 3. Middle molecules re-examined.
    Henderson LW
    Nephron; 1978; 22(1-3):146-52. PubMed ID: 745634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation endproducts (AGEs) as uremic toxins.
    Schwenger V; Zeier M; Henle T; Ritz E
    Nahrung; 2001 Jun; 45(3):172-6. PubMed ID: 11455783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dialysable solutes in the mediation of uremic encephalopathy in the rat.
    Lipman JJ; Lawrence PL; DeBoer DK; Shoemaker MO; Sulser D; Tolchard S; Teschan PE
    Kidney Int; 1990 Mar; 37(3):892-900. PubMed ID: 2313978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal versus continuous versus intermittent therapies for removal of uremic toxins.
    Clark WR; Henderson LW
    Kidney Int Suppl; 2001 Feb; 78():S298-303. PubMed ID: 11169030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuropathy and encephalopathy in dialysis treatment].
    Miyahara T; Shimojo S; Iwazawa A; Miyashima T; Yanagisawa O
    Nihon Rinsho; 1972 Dec; 30(12):2521-8. PubMed ID: 4347357
    [No Abstract]   [Full Text] [Related]  

  • 9. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental studies of toxic factors in uremic encephalopathy.
    Teschan PE; Carter CB; Taub E
    Arch Intern Med; 1970 Nov; 126(5):838-40. PubMed ID: 4990918
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D
    Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do middle molecules cause uremic intoxication? (Con).
    Kjellstrand CM
    Am J Kidney Dis; 1981 Jul; 1(1):51-6. PubMed ID: 7332001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription criteria in peritoneal dialysis.
    Gotch FA
    Perit Dial Int; 1994; 14 Suppl 3():S83-7. PubMed ID: 7948283
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum an uremic toxin.
    D'Haese PC; Van de Vyver FL; Lamberts LV; De Broe ME
    Adv Exp Med Biol; 1987; 223():89-96. PubMed ID: 3447454
    [No Abstract]   [Full Text] [Related]  

  • 15. Uremic toxins and peritoneal dialysis.
    Lameire N; Vanholder R; De Smet R
    Kidney Int Suppl; 2001 Feb; 78():S292-7. PubMed ID: 11169029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular system in continuous ambulatory peritoneal dialysis.
    Giangrande A
    Contrib Nephrol; 1990; 84():52-9. PubMed ID: 2261782
    [No Abstract]   [Full Text] [Related]  

  • 19. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
    Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
    Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
    [No Abstract]   [Full Text] [Related]  

  • 20. Membranes and their removal of uremic toxins.
    Hoenich NA
    Adv Exp Med Biol; 1987; 223():253-62. PubMed ID: 3447443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.